Clinical trial • Oncology
STX-721/PFL-721 for Non-small cell lung cancer | Locally advanced or metastatic non-small cell lung cancer
Clinical trial of STX-721/PFL-721 for Non-small cell lung cancer | Locally advanced or metastatic non-small cell lung cancer. 123 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Non-small cell lung cancer | Locally advanced or metastatic non-small cell lung cancer
Key dates
- Initial CTIS Submission Date
- 10-10-2023
- First CTIS Authorization Date
- 19-02-2024
Trial design
Clinical trial across 11 sites in Netherlands, Spain, Germany and others.
- Target Sample Size
- 123
Recruitment
- Planned Sample Size
- 123
- Recruitment Window Months
- 39
Geography
- Total Number Of Sites
- 11
- Total Number Of Participants
- 128
Netherlands
- Earliest CTIS Part Ii Submission Date
- 08-02-2024
- Latest Decision Or Authorization Date
- 25-11-2025
- Processing Time Days
- 656
- Number Of Sites
- 1
- Number Of Participants
- 13
Sites
- Site Name
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
- Department Name
- Medical Oncology
- Principal Investigator Name
- Gerrina Ruiter
- Principal Investigator Email
- CPM-CRU@nki.nl
- Contact Person Name
- Gerrina Ruiter
- Contact Person Email
- CPM-CRU@nki.nl
Spain
- Earliest CTIS Part Ii Submission Date
- 16-01-2024
- Latest Decision Or Authorization Date
- 31-10-2025
- Processing Time Days
- 654
- Number Of Sites
- 4
- Number Of Participants
- 46
Sites
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Medical Oncology
- Principal Investigator Name
- Enriqueta Felip
- Principal Investigator Email
- efelip@vhio.net
- Contact Person Name
- Enriqueta Felip
- Contact Person Email
- efelip@vhio.net
- Site Name
- Hospital Universitario Ramon Y Cajal
- Department Name
- Medical Oncology
- Principal Investigator Name
- Pilar Garrido
- Principal Investigator Email
- pilargarridol@gmail.com
- Contact Person Name
- Pilar Garrido
- Contact Person Email
- pilargarridol@gmail.com
- Site Name
- University Hospital Virgen Del Rocio S.L.
- Department Name
- Oncologia Medica
- Principal Investigator Name
- Amparo Sanchez Gastaldo
- Principal Investigator Email
- asanchezgastaldo@gmail.com
- Contact Person Name
- Amparo Sanchez Gastaldo
- Contact Person Email
- asanchezgastaldo@gmail.com
- Site Name
- Hospital Universitario Regional De Malaga
- Department Name
- Oncologia Medica
- Principal Investigator Name
- Manuel Cobo Dols
- Principal Investigator Email
- manuelcobodols@yahoo.es
- Contact Person Name
- Manuel Cobo Dols
- Contact Person Email
- manuelcobodols@yahoo.es
Germany
- Earliest CTIS Part Ii Submission Date
- 03-01-2024
- Latest Decision Or Authorization Date
- 31-10-2025
- Processing Time Days
- 667
- Number Of Sites
- 2
- Number Of Participants
- 23
Sites
- Site Name
- Charite Universitaetsmedizin Berlin KöR
- Department Name
- Klinik für Onkologie und Hämatologie
- Principal Investigator Name
- Damian Rieke
- Principal Investigator Email
- studien-imt@charite.de
- Contact Person Name
- Damian Rieke
- Contact Person Email
- studien-imt@charite.de
- Site Name
- Technische Universitaet Dresden
- Department Name
- Nationales Centrum für Tumorerkrankungen Dresden
- Principal Investigator Name
- Martin Wermke
- Principal Investigator Email
- martin.wermke@uniklinikum-dresden.de
- Contact Person Name
- Martin Wermke
- Contact Person Email
- martin.wermke@uniklinikum-dresden.de
France
- Earliest CTIS Part Ii Submission Date
- 06-02-2024
- Latest Decision Or Authorization Date
- 26-11-2025
- Processing Time Days
- 659
- Number Of Sites
- 4
- Number Of Participants
- 46
Sites
- Site Name
- Institut Curie
- Department Name
- Département Oncologie Médicale
- Principal Investigator Name
- Pauline DU RUSQUEC
- Principal Investigator Email
- pauline.durusquec@pierre-fabre.com
- Contact Person Name
- Pauline DU RUSQUEC
- Contact Person Email
- pauline.durusquec@pierre-fabre.com
- Site Name
- Institut Universitaire Du Cancer Toulouse-Oncopole
- Department Name
- Oncopole Claudius Regaud IUCT-O
- Principal Investigator Name
- Julien Mazieres
- Principal Investigator Email
- mazieres.j@chu-toulouse.fr
- Contact Person Name
- Julien Mazieres
- Contact Person Email
- mazieres.j@chu-toulouse.fr
- Site Name
- Institut De Cancerologie De L Ouest
- Department Name
- Site René Gauducheau
- Principal Investigator Name
- Sandrine HIRET
- Principal Investigator Email
- sandrine.hiret@ico.unicancer.fr
- Contact Person Name
- Sandrine HIRET
- Contact Person Email
- sandrine.hiret@ico.unicancer.fr
- Site Name
- Institut Gustave Roussy
- Department Name
- Drug Development Department
- Principal Investigator Name
- Anas Gazzah
- Principal Investigator Email
- anas.gazzah@gustaveroussy.fr
- Contact Person Name
- Anas Gazzah
- Contact Person Email
- anas.gazzah@gustaveroussy.fr
Sponsor
Primary sponsor
- Full Name
- Pierre Fabre Medicament
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- STX-721/PFL-721
Related trials
Other published trials that may interest you.
- PF-08634404 for Non-small cell lung cancer | Locally advanced or metastatic non-small cell lung cancer
- gilteritinib for Non-small cell lung cancer | Locally advanced or metastatic non-small cell lung cancer
- RINATABART SESUTECAN for Non-small cell lung cancer | Locally advanced or metastatic non-small cell lung cancer
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer